News 2025-10-10
Porton Newsletter - September 2025 Recap











Others
More
News 2026-09-30
Porton Newsletter - September, 2026 Recap
Porton Recognized by LyncBio Therapeutics for ADC Payload-Linker CMC Capabilities Porton Chongqing Liangjiang Drug Product Manufacturing Site Earns Recertification of ISO 14001 & ISO 45001 PMO Therapeutics: Technical Review and Manufacturing Platform Capabilities

News 2026-09-29
Porton Recognized by LyncBio Therapeutics for ADC Payload-Linker CMC Capabilities
Porton, as the project's CDMO partner, completed process development and manufactured non-GMP toxicology batches and GMP clinical trial materials for LYNC-101's payload-linker.